Schedule 13G ownership disclosure
Cellular Biomedicine Group, Inc.
Security class unavailable
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 483,309
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-16-001895
- Form type
- SC 13G
- Filer
- Cellular Biomedicine Group, Inc.
- CIK
- CIK 1378624
- Filed
- Feb 11, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership